The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
www.marketwatch.com
#Modernas #stock #rallies #deal #patent #dispute #clears #vaccine #pipeline
Related Posts

Meta’s Instagram orders employees back to the office 5 days a week
Instagram has installed a new privacy setting which will default all new and existing underage accounts to an automatic private…
Inflation is quietly chipping away at most Americans’ main source of wealth
Home-price growth continues to slow in the 20 biggest metro areas in the U.S., as the housing market buckles under…

MongoDB stock skyrockets 22% on AI, cloud database platform growth
MongoDB shares ripped 22% higher on Tuesday after the company blew past Wall Street’s third-quarter expectations and lifted its forecast…

